Approval · Notice of Compliance 343 · 2002
ORB-CAPTOPRIL: Notice of Compliance 343
Issued September 19, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 343
- Date
- September 19, 2002
- Company
- Orbus Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
- Canadian reference product
- CAPOTEN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORB-CAPTOPRIL | 02246587 | Cancelled (Unreturned Annual) |
| ORB-CAPTOPRIL | 02246588 | Cancelled (Unreturned Annual) |